Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$836M |
| 2 |
Microsoft
MSFT
|
+$748M |
| 3 |
Cigna
CI
|
+$560M |
| 4 |
3M
MMM
|
+$558M |
| 5 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$535M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$568M |
| 2 |
Zoom
ZM
|
+$557M |
| 3 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$516M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$479M |
| 5 |
Unity
U
|
+$476M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.72% |
| 2 | Healthcare | 11.35% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 8.31% |
| 5 | Communication Services | 5.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4401
Butterfly Network
BFLY
$2.35B
| $1.77M | ﹤0.01% |
375,697
-46,808
| -11% | -$247K |
|
|
HLVX
4402
DELISTED
HilleVax
HLVX
| $1.76M | ﹤0.01% |
103,116
-986
| -0.9% | -$14.3K |
|
|
VRAY
4403
DELISTED
ViewRay, Inc.
VRAY
| $1.76M | ﹤0.01% |
483,974
-63,303
| -12% | -$212K |
|
|
PMO
4404
Franklin Municipal Opportunities Trust
PMO
$290M
| $1.76M | ﹤0.01% |
179,608
+1,011
| +0.6% | +$11.9K |
|
4405
Digimarc Corp
DMRC
$169M
| $1.75M | ﹤0.01% |
129,298
+6,891
| +6% | +$111K |
|
|
SOVO
4406
DELISTED
Sovos Brands, Inc. Common Stock
SOVO
| $1.75M | ﹤0.01% |
123,098
+105,940
| +617% | +$1.55M |
|
4407
Viemed Healthcare
VMD
$350M
| $1.75M | ﹤0.01% |
291,927
+115,619
| +66% | +$742K |
|
|
FUND
4408
Sprott Focus Trust
FUND
$320M
| $1.75M | ﹤0.01% |
254,285
+32,439
| +15% | +$253K |
|
|
PHD
4409
DELISTED
Pioneer Floating Rate Fund
PHD
| $1.74M | ﹤0.01% |
202,273
-7,072
| -3% | -$64.4K |
|
4410
FlexShares Morningstar Developed Markets ex-US Factor Tilt Index Fund
TLTD
$691M
| $1.74M | ﹤0.01% |
33,724
+29
| +0.1% | +$1.67K |
|
|
AVDL
4411
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.74M | ﹤0.01% |
346,852
+30,491
| +10% | +$168K |
|
4412
Telos
TLS
$339M
| $1.74M | ﹤0.01% |
195,407
+21,451
| +12% | +$198K |
|
|
PRVB
4413
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.74M | ﹤0.01% |
385,512
+49,605
| +15% | +$226K |
|
|
WBX
4414
Wallbox
WBX
$75.2M
| $1.73M | ﹤0.01% |
10,989
+8,318
| +311% | +$1.48M |
|
4415
Aehr Test Systems
AEHR
$4.37B
| $1.73M | ﹤0.01% |
122,497
+47,199
| +63% | +$635K |
|
|
SRNE
4416
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $1.73M | ﹤0.01% |
1,098,967
-1,873,064
| -63% | -$4.25M |
|
4417
IonQ
IONQ
$18.7B
| $1.72M | ﹤0.01% |
339,272
+19,297
| +6% | +$107K |
|
|
OTLY
4418
Oatly Group
OTLY
$441M
| $1.72M | ﹤0.01% |
32,701
-6,610
| -17% | -$457K |
|
4419
Global Industrial
GIC
$1.48B
| $1.72M | ﹤0.01% |
63,931
-20,894
| -25% | -$658K |
|
4420
CrossAmerica Partners
CAPL
$900M
| $1.71M | ﹤0.01% |
91,179
-6,984
| -7% | -$144K |
|
4421
Intercorp Financial Services
IFS
$6.04B
| $1.7M | ﹤0.01% |
84,963
-4,159
| -5% | -$94.6K |
|
4422
Larimar Therapeutics
LRMR
$453M
| $1.7M | ﹤0.01% |
530,293
+485
| +0.1% | +$1.22K |
|
4423
ThredUp
TDUP
$403M
| $1.7M | ﹤0.01% |
921,713
+555,734
| +152% | +$1.39M |
|
4424
KraneShares MSCI All China Health Care Index ETF
KURE
$106M
| $1.69M | ﹤0.01% |
95,597
+934
| +1% | +$19.5K |
|
4425
Expro Ltd
XPRO
$2.1B
| $1.69M | ﹤0.01% |
133,146
-49,266
| -27% | -$597K |
|
Similar funds
Morgan Stanley's Q3 2022 Portfolio in Review
As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.
- Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
- Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
- Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
- Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
- Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
- Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.
Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.